Plain-English translation of NCT06849063 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Pancreatic cancer is very aggressive and difficult to treat. This study uses a special type of MRI scan called 3D-MRE (three-dimensional magnetic resonance elastography) to measure how stiff your tumor is. The stiffness of a tumor can tell doctors important information about how it might behave and respond to treatment.
Doctors currently have limited ways to predict which pancreatic cancer patients will do better or worse after treatment. This study explores whether measuring tumor stiffness with this advanced imaging can help doctors understand your specific cancer better and plan the best treatment approach for you.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a specialized MRI scan called 3D-MRE that measures how stiff your tumor is. This scan is noninvasive and painless. You will be in one of two groups depending on whether your cancer can be surgically removed or not. After your scan, you will be followed for at least three to six months so researchers can track your health outcomes and see if the stiffness measurement predicted how you responded to treatment.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China